02 Mar Dr. Warren Flood steps up as CEO of Bio-Me

Bio-Me has appointed Warren Flood as its CEO. Morten Isaksen has joined the board of directors and will continue as Chief Innovation Officer.

OSLO, Norway, March 01, 2022 – Microbiome precision medicine company Bio-Me today announced that Dr. Warren Flood has become CEO following his successful period as COO. Previous CEO Dr. Morten Isaksen moves up to the Board and will also continue as Chief Innovation Officer with a focus on longer term and higher-value clinical applications for the company’s Precision Microbiome Profiling (PMP™) technology. These steps are part of the company’s strategic plan to position Bio-Me as a leader in microbiome-based Precision Medicine and are in advance of a new funding round.

Dr. Flood is a microbiologist with a key interest in the design and development of improved molecular techniques for microbiome analysis and is currently chairman of the Pharmabiotics Research Institute OMICs task group. He holds a PhD in microbiology and an MSc in immunology and immunogenetics from the University of Manchester.

Dr. Flood commented: “I am honored to have been appointed CEO of Bio-Me, particularly at this exciting time in the company’s development. Morten first attracted me to the company and has built excellent foundations for future growth. As COO I have witnessed first-hand the growing interest in PMP™ and look forward to further realizing this potential.”

Dr. Morten Isaksen added: “I am delighted to see Warren take over as my successor. I look forward to supporting him from both my new position on the board and as CIO in our shared mission to make Bio-Me a leader in microbiome-based Precision Medicine.”

Dr. Carl-Christian Gilhuus-Moe, Chairman of Bio-Me added: “We are really pleased to see how the company has developed with Dr. Isaksen as the CEO. Him stepping up to the Board and focusing on the clinical applications will help us to have a stronger focus on the key market segments in the company and is a strategic choice to position the company for further growth.”